Hypomagnesaemic tetany associated with repeated courses of intravenous tobramycin in a patient with cystic fibrosis

被引：6
|
作者：
Adams, JP [1 ]
Conway, SP [1 ]
Wilson, C [1 ]
机构：
[1] Seacroft Hosp, Reg Adult Cyst Fibrosis Ctr, Leeds LS14 6UH, W Yorkshire, England
来源：
RESPIRATORY MEDICINE | 1998年 / 92卷 / 03期
关键词：
D O I：
10.1016/S0954-6111(98)90319-5
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
[No abstract available]
引用
收藏
页码：602 / 604
页数：3
相关论文
共 50 条
  • [31] Prospective cohort study of ototoxicity in persons with cystic fibrosis following a single course of intravenous tobramycin *
    Garinis, Angela
    Gleser, Malcolm
    Johns, Alexis
    Larsen, Erik
    Vachhani, Jay
    JOURNAL OF CYSTIC FIBROSIS, 2021, 20 (02) : 278 - 283
  • [32] Inhaled tobramycin solution-associated recurrent eosinophilia and severe persistent bronchospasm in a patient with cystic fibrosis: A case report
    Santos R.P.
    Awa E.
    Anbar R.D.
    BMC Pediatrics, 7 (1)
  • [33] Safety of repeated intermittent courses of aerosolized recombinant human deoxyribonuclease in patients with cystic fibrosis
    Eisenberg, JD
    Aitken, ML
    Dorkin, HL
    Harwood, IR
    Ramsey, BW
    Schidlow, DV
    Wilmott, RW
    Wohl, ME
    Fuchs, HJ
    Christiansen, DH
    Smith, AL
    JOURNAL OF PEDIATRICS, 1997, 131 (01): : 118 - 124
  • [34] Renal impairment in cystic fibrosis patients due to repeated intravenous aminoglycoside use
    Al-Aloul, M
    Miller, H
    Alapati, S
    Stockton, PA
    Ledson, MJ
    Walshaw, MJ
    PEDIATRIC PULMONOLOGY, 2005, 39 (01) : 15 - 20
  • [35] EFFICACY AND SAFETY OF COLISTIN COMPARED TO TOBRAMYCIN FOR INTRAVENOUS TREATMENT OF ACUTE PULMONARY EXACERBATIONS IN ADULTS WITH CYSTIC FIBROSIS
    Saavedra, M. T.
    Poch, K.
    Casciano, M.
    Kiser, T.
    Fish, D.
    Kuk, K.
    Nichols, D.
    Taylor-Cousar, J. L.
    Strand, M.
    Nick, J. A.
    PEDIATRIC PULMONOLOGY, 2015, 50 : 355 - 355
  • [36] Efficacy And Safety Of Colistin Compared To Tobramycin For Intravenous Treatment Of Acute Pulmonary Exacerbations In Adults With Cystic Fibrosis
    Saavedra, M.
    Poch, K. R.
    Casciano, M.
    Kiser, T. H.
    Fish, D.
    Morris, A.
    Nichols, D. P.
    Taylor-Cousar, J. L.
    Strand, M.
    Nick, J. A.
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2015, 191
  • [37] Pharmacokinetic modelling of a once-daily dosing regimen for intravenous tobramycin in paediatric cystic fibrosis patients
    Lam, Wallace
    Tjon, James
    Seto, Winnie
    Dekker, Allison
    Wong, Cecile
    Atenafu, Eshetu
    Bitnum, Ari
    Waters, Valerie
    Yau, Yvonne
    Solomon, Melinda
    Ratjen, Felix
    JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 2007, 59 (06) : 1135 - 1140
  • [38] PHOTOSENSITIVITY DUE TO AMBULATORY INTRAVENOUS CEFTAZIDIME IN CYSTIC-FIBROSIS PATIENT
    VINKS, SATMM
    HEIJERMAN, HGM
    DEJONGE, P
    BAKKER, W
    LANCET, 1993, 341 (8854): : 1221 - 1222
  • [39] ACCIDENTAL INTRAVENOUS ADMINISTRATION OF ENTERAL FEEDS BY A PATIENT WITH CYSTIC-FIBROSIS
    BURDON, JT
    MORTON, AM
    CONWAY, SP
    CLINICAL NUTRITION, 1995, 14 (05) : 313 - 315
  • [40] An 18-Month Study of the Safety and Efficacy of Repeated Courses of Inhaled Aztreonam Lysine in Cystic Fibrosis
    Oermann, Christopher M.
    Retsch-Bogart, George Z.
    Quittner, Alexandra L.
    Gibson, Ronald L.
    McCoy, Karen S.
    Montgomery, A. Bruce
    Cooper, Peter J.
    PEDIATRIC PULMONOLOGY, 2010, 45 (11) : 1121 - 1134
12345